Table 6 Demographic and clinical characteristics of PV patients
| Â | GCC genotype | Â | |
|---|---|---|---|
| Â | No (n= 10) | Yes (n= 23) | Pvalue |
Age, mean (SD) | 63.2 (12.4) | 60.7 (14.0) | 0.5779 |
Sex | Â | Â | Â |
   Female | 4 (40%) | 13 (56.7%) | 0.4646 |
   Male | 6 (60%) | 10 (43.5%) |  |
Splenomegaly | 5/10 (50%) | 12/23 (52.2%) | 0.7413 |
Thrombosis | 3/10 (30%) | 4/20 (20%) | 0.4786 |
Therapy requirement | 9/10 (90%) | 22/23 (95.7%) | 0.2585 |
Cytogenetic abnormality | 0/10 (0%) | 3/23 (13%) | 0.1781 |
MF evolution | 3/10 (30%) | 3/23 (13%) | 0.0924 |
AML evolution | 1/10 (10%) | 3/23 (13%) | 0.7614 |
Survival, median (SD) | 3427 (2336) | 2840 (2822) | 0.7583 |